RwHealth, a London-based artificial intelligence (AI) provider, announced a raise of $8.4 million (€7.2M) in Series A funding. Maven VC and Guinness Asset Management led the round, along with ICON Corporate Finance.
The capital will help clinicians manage elective recovery backlogs in the NHS and advanced clinical research in areas such as acute myeloid leukemia (AML), CAR-T, and other diseases as the healthcare industry attempts to recover post-COVID.
Round: Series A
Funding Month: October 2021
Lead Investors: Maven VC and Guinness Asset Management
Additional Investors: ICON Corporate Finance
Company Website: https://realworld.health/
Software Category: Data Science Platform (DSP)
About the Company: Founded in 2017, RwHealth’s platform combines AI machine learning and data science to give healthcare providers access to data that can aid their decision-making. RwHealth’s deep analytical capability can be used to make predictions, model treatment options, improve safety and increase efficiency so that clinicians can deliver better care to more people. Its platform has been used to help UK hospitals combat bed shortages and tackle waiting list issues caused by the pandemic. The startup works with more than 40 providers in the UK and internationally and its AI technology has processed more than 10.5 million patients in the UK and a further 5.5 million across the Middle East and Australia.